Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2023, 2023, roč. 18, č. 2, s. 160-161.